Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001

被引:29
作者
Van Damme, P [1 ]
Vorsters, A [1 ]
机构
[1] Univ Antwerp, Ctr Evaluat Vaccinat, WHO Collaborating Ctr Prevent & Control Viral Hep, Dept Epidemiol & Social Med, B-2610 Antwerp, Belgium
关键词
hepatitis B; universal vaccination; Europe;
D O I
10.1002/jmv.10091
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the nine years since the Global Advisory G roup of the Expanded Programme on Immunisation (WHO) set 1997 as the target for integrating hepatitis B vaccination into national immunisation programmes worldwide, 129 countries have included hepatitis B vaccine as part of their routine infant or adolescent immunisation programmes (June 2001). By the end of 2002, 41 out of the 51 countries of the WHO European Region will be implementing universal hepatitis B immunisation. The rewards of effective implementation of the programmes in countries that started 10 years ago are becoming apparent; and their success offers an exemplary model for other countries. Some other countries, however, have difficulties to incorporate hepatitis B vaccine into universal childhood immunisation programmes, because of major economic constrains and the inability to procure a constant vaccine supply. The next decade will be characterised by expanded use of hepatitis B vaccines and the increasing efforts to sustain vaccine programmes and make the vaccine available to those countries and regions that cannot afford it. In Europe, as well as in the rest of the world, work still remains to be done to support and implement interventions that will bring us closer to the WHO goal and to eradicate hepatitis B. J. Med. ViroL 67.433-439,2002. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 27 条
[1]   Ad hoc survey of hepatitis B vaccination campaign in newborns of HBsAg positive mothers and in 12-year-old subjects in southern Italy [J].
Adamo, B ;
Stroffolini, T ;
Sagliocca, L ;
Simonetti, A ;
Iadanza, F ;
Fossi, E ;
Tancredi, F ;
Mele, A .
VACCINE, 1998, 16 (08) :775-777
[2]   A FRAMEWORK FOR THE EVALUATION OF VACCINES FOR USE IN THE EXPANDED PROGRAM ON IMMUNIZATION [J].
AYLWARD, B ;
KANE, M ;
BATSON, A ;
SCOTT, RM .
VACCINE, 1994, 12 (13) :1155-1159
[3]   Success stories in the implementation of universal hepatitis B vaccination: an update on Italy [J].
Bonanni, P ;
Crovari, P .
VACCINE, 1998, 16 :S38-S42
[4]  
BONANNI P, 1995, VACCINE, V13, pS68
[5]   Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children [J].
Chang, MH ;
Chen, CJ ;
Lai, MS ;
Hsu, HM ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Shau, WY ;
Chen, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1855-1859
[6]   12-YEAR FOLLOW-UP-STUDY OF HEPATITIS-B IMMUNIZATION OF SENEGALESE INFANTS [J].
COURSAGET, P ;
LEBOULLEUX, D ;
SOUMARE, M ;
LECANN, P ;
YVONNET, B ;
CHIRON, JP ;
COLLSECK, AM ;
DIOPMAR, I .
JOURNAL OF HEPATOLOGY, 1994, 21 (02) :250-254
[7]   Editorial:: Vaccination in the 21st century -: new funds, new strategies? [J].
Cutts, FT .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2000, 5 (03) :157-159
[8]  
DELATORRE J, 1995, VACCINE, V13, pS72
[9]   Prevention and control of hepatitis B in central and eastern Europe and the newly independent states, Siofok, Hungary, 6-9 October 1996 [J].
FitzSimons, D ;
VanDamme, P .
VACCINE, 1997, 15 (15) :1595-1597
[10]  
GATCHEVA N, 1995, VACCINE, V13, pS82